Psyence Biomedical Ltd. (PBM) Accounts Payables (2023 - 2026)
Psyence Biomedical (PBM) posted quarterly Accounts Payables of $407714.0 for Q1 2026, up 3.41% year-over-year from $394270.0 in Q1 2025, and down 36.76% quarter-over-quarter from $644700.0 in Q3 2025.
Psyence Biomedical Ltd. (PBM) Accounts Payables (2023 - 2026) Analysis & Trends
Psyence Biomedical's Accounts Payables history runs 4 years deep, the most recent figure standing at $407714.0 for Q1 2026.
- In Q1 2026, Accounts Payables rose 3.41% year-over-year to $407714.0; the TTM figure through Mar 2026 stood at $407714.0 (up 3.41% YoY), while the FY2026 annual figure was $407714.0, up 3.41% from the prior year.
- Accounts Payables for Q1 2026 stood at $407714.0, down from $644700.0 in the prior quarter.
- The five-year high for Accounts Payables was $1007.7 billion in Q3 2023, with the low at $394270.0 in Q1 2025.
- The 4-year median for Accounts Payables is $755202.0 (2024), against an average of $144.0 billion.
- The sharpest annual moves came in 2024 and 2026: Accounts Payables plunged 100.0% in 2024, then increased 3.41% in 2026.
- Psyence Biomedical's Accounts Payables stood at $1007.7 billion in 2023, then slumped by 100.0% to $858558.0 in 2024, then declined by 24.91% to $644700.0 in 2025, then plunged by 36.76% to $407714.0 in 2026.
- Business Quant data shows PBM's Accounts Payables at $407714.0 in Q1 2026, $644700.0 in Q3 2025, and $394270.0 in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 407,714.00 |
| Sep 30, 2025 | 644,700.00 |
| Mar 31, 2025 | 394,270.00 |
| Sep 30, 2024 | 858,558.00 |
| Mar 31, 2024 | 755,202.00 |
| Sep 30, 2023 | 1,007.70 Bn |
| Mar 31, 2023 | 1.79 Mn |